Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Neurology
|
March 24, 2004
Rapid treatment of "wearing off" in Parkinson's disease
David M Swope
Pharmacotherapy
|
October 4, 2003
Essential tremor: diagnosis and treatment
Jack J Chen, David M Swope
Journal of Clinical Pharmacology
|
July 20, 2005
Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease
Jack J Chen, David M Swope
Pharmacotherapy
|
November 29, 2007
Pharmacotherapy for Parkinson's disease
Jack J Chen, David M Swope
Clinical Therapeutics
|
November 24, 2007
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease
Jack J Chen, David M Swope, Khashayar Dashtipour
Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|
February 27, 2013
Diffusion of botulinum toxins
Matthew A Brodsky, David M Swope, David Grimes
Pharmacotherapy
|
May 24, 2006
Update on apomorphine for the rapid treatment of hypomobility ("off") episodes in Parkinson's disease
Crystal D Obering, Jack J Chen, David M Swope
Pharmacotherapy
|
December 2, 2009
Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease
Jack J Chen, David M Swope, Khashayar Dashtipour, et al.
Clinical Therapeutics
|
July 4, 2012
Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature
Jack J Chen, William G Ondo, Khashayar Dashtipour, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Neurology
|
March 24, 2004
Rapid treatment of "wearing off" in Parkinson's disease
David M Swope
Pharmacotherapy
|
October 4, 2003
Essential tremor: diagnosis and treatment
Jack J Chen, David M Swope
Journal of Clinical Pharmacology
|
July 20, 2005
Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease
Jack J Chen, David M Swope
Pharmacotherapy
|
November 29, 2007
Pharmacotherapy for Parkinson's disease
Jack J Chen, David M Swope
Clinical Therapeutics
|
November 24, 2007
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease
Jack J Chen, David M Swope, Khashayar Dashtipour
Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|
February 27, 2013
Diffusion of botulinum toxins
Matthew A Brodsky, David M Swope, David Grimes
Pharmacotherapy
|
May 24, 2006
Update on apomorphine for the rapid treatment of hypomobility ("off") episodes in Parkinson's disease
Crystal D Obering, Jack J Chen, David M Swope
Pharmacotherapy
|
December 2, 2009
Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease
Jack J Chen, David M Swope, Khashayar Dashtipour, et al.
Clinical Therapeutics
|
July 4, 2012
Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature
Jack J Chen, William G Ondo, Khashayar Dashtipour, et al.
Page
of 1